Stephen Crystal1, Molly Nowels2, Mark Olfson3, Hillary Samples4, Arthur Robinson Williams5, Peter Treitler6. 1. Center for Health Services Research, Institute for Health, Rutgers University, 112 Paterson Street, New Brunswick, NJ 08901, USA; School of Social Work, Rutgers University, 536 George Street, New Brunswick, NJ 08901, USA; School of Public Health, Department of Health Behavior, Society and Policy, Rutgers University, 683 Hoes Ln W, Piscataway, NJ 08854, USA. Electronic address: scrystal@ifh.rutgers.edu. 2. Center for Health Services Research, Institute for Health, Rutgers University, 112 Paterson Street, New Brunswick, NJ 08901, USA; School of Public Health, Department of Health Behavior, Society and Policy, Rutgers University, 683 Hoes Ln W, Piscataway, NJ 08854, USA. Electronic address: mnowels@ifh.rutgers.edu. 3. Vagelos College of Physicians and Surgeons, 630 W 168th Street, Columbia University, New York, NY 10032, USA; Mailman School of Public Health, Columbia University, 722 W 168th Street, New York, NY 10032, USA. Electronic address: Mark.Olfson@nyspi.columbia.edu. 4. Center for Health Services Research, Institute for Health, Rutgers University, 112 Paterson Street, New Brunswick, NJ 08901, USA; School of Public Health, Department of Health Behavior, Society and Policy, Rutgers University, 683 Hoes Ln W, Piscataway, NJ 08854, USA. Electronic address: h.samples@rutgers.edu. 5. Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Drive, New York, NY 10032, USA. 6. Center for Health Services Research, Institute for Health, Rutgers University, 112 Paterson Street, New Brunswick, NJ 08901, USA; School of Social Work, Rutgers University, 536 George Street, New Brunswick, NJ 08901, USA. Electronic address: peter.treitler@rutgers.edu.
Abstract
OBJECTIVE: Medically treated opioid overdoses identify a population at high risk of subsequent mortality and need for treatment. This study reports on medically treated opioid overdose trends in a state with rapid fentanyl spread. METHODS: We conducted stratified trend analysis of medically treated overdose due to heroin, synthetic opioids, methadone, or other natural opioids among New Jersey Medicaid beneficiaries aged 12-64 years (2014-2019); evaluated associations with demographics and co-occurring conditions; and examined trends in fentanyl penetration in suspected heroin seizures from New Jersey State Police data. RESULTS: Overdose risk more than tripled from 2014 to 2019, from 120.5 to 426.8 per 100,000 person-years, respectively. Increases primarily involved heroin and synthetic opioids and were associated with co-occurring alcohol and other non-opioid drug disorders, major depressive disorder, and hepatitis C. Concurrent changes in the drug exposure environment (2015-2019) included an increase in fentanyl penetration (proportion of suspected heroin seizures that included fentanyls) from 2% to 80%, and a decrease in the proportion of Medicaid beneficiaries who received opioid analgesic prescriptions from 23% to 13%. CONCLUSION: Results document a rapid increase in overdose risk among individuals with opioid use disorder in an environment in which fentanyl is highly prevalent, and highlight the need for intensified services and engagement of non-treatment seekers, and integrated models to address multiple co-occurring conditions and risk factors.
OBJECTIVE: Medically treated opioid overdoses identify a population at high risk of subsequent mortality and need for treatment. This study reports on medically treated opioid overdose trends in a state with rapid fentanyl spread. METHODS: We conducted stratified trend analysis of medically treated overdose due to heroin, synthetic opioids, methadone, or other natural opioids among New Jersey Medicaid beneficiaries aged 12-64 years (2014-2019); evaluated associations with demographics and co-occurring conditions; and examined trends in fentanyl penetration in suspected heroin seizures from New Jersey State Police data. RESULTS: Overdose risk more than tripled from 2014 to 2019, from 120.5 to 426.8 per 100,000 person-years, respectively. Increases primarily involved heroin and synthetic opioids and were associated with co-occurring alcohol and other non-opioid drug disorders, major depressive disorder, and hepatitis C. Concurrent changes in the drug exposure environment (2015-2019) included an increase in fentanyl penetration (proportion of suspected heroin seizures that included fentanyls) from 2% to 80%, and a decrease in the proportion of Medicaid beneficiaries who received opioid analgesic prescriptions from 23% to 13%. CONCLUSION: Results document a rapid increase in overdose risk among individuals with opioid use disorder in an environment in which fentanyl is highly prevalent, and highlight the need for intensified services and engagement of non-treatment seekers, and integrated models to address multiple co-occurring conditions and risk factors.
Authors: Lisa Clemans-Cope; Jane B Wishner; Eva H Allen; Nicole Lallemand; Marni Epstein; Brenda C Spillman Journal: J Subst Abuse Treat Date: 2017-10-06
Authors: Dario Tedesco; Steven M Asch; Catherine Curtin; Jennifer Hah; Kathryn M McDonald; Maria P Fantini; Tina Hernandez-Boussard Journal: Health Aff (Millwood) Date: 2017-10-01 Impact factor: 6.301
Authors: Piyameth Dilokthornsakul; Gina Moore; Jonathan D Campbell; Robert Lodge; Cathy Traugott; Judy Zerzan; Richard Allen; Robert L Page Journal: J Pain Date: 2015-12-22 Impact factor: 5.820
Authors: Perrine Roux; Maria A Sullivan; Julien Cohen; Lionel Fugon; Jermaine D Jones; Suzanne K Vosburg; Ziva D Cooper; Jeanne M Manubay; Shanthi Mogali; Sandra D Comer Journal: Pain Date: 2013-05-07 Impact factor: 6.961
Authors: Jeffrey F Scherrer; Joanne Salas; Richard Grucza; Mark D Sullivan; Patrick J Lustman; Laurel A Copeland; Jane C Ballantyne Journal: J Affect Disord Date: 2020-09-28 Impact factor: 4.839
Authors: Stephen Crystal; Molly Nowels; Hillary Samples; Mark Olfson; Arthur Robin Williams; Peter Treitler Journal: Drug Alcohol Depend Date: 2022-01-10 Impact factor: 4.492
Authors: Benjamin J Oldfield; Yu Li; Rachel Vickers-Smith; Declan T Barry; Stephen Crystal; Kirsha S Gordon; Robert D Kerns; Emily C Williams; Brandon D L Marshall; E Jennifer Edelman Journal: Alcohol Clin Exp Res Date: 2022-03-16 Impact factor: 3.928
Authors: Jamey J Lister; Guijin Lee; Jennifer D Ellis; Emily Pasman; Elizabeth Agius; Stella M Resko Journal: Front Psychiatry Date: 2022-05-02 Impact factor: 5.435